caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1801837240

NPI 1801837240

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
No data available for this provider in 2024.
QUALITY · MIPS · 2024
No data available for this provider in 2024.
REFERRAL NETWORK

Where NPI 1801837240's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 14 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Ameripath New York Llc
Clinical Laboratory · White Plains, NY
97128
HORST, BASIL5053
David Silvers
Pathology · New York, NY
4980
Bioreference Health, Llc
Clinical Laboratory · Elmwood Park, NJ
3858
Laboratory Corporation Of America Holdings
Clinical Laboratory · Raritan, NJ
3761
BOWDEN, JEFFREY2535
Avraham Sokoloff
Physician Assistant · Monroe, NY
2532
Edward Desciak
Dermatology · Pomona, NY
2025
Barrett Eisenstat
Dermatology · Oceanside, NY
1928
Johanna Baeuerle
Dermatology · Nyack, NY
1525
SUTTON, JOSEPH1523
Dawn Barilli
Physician Assistant · Monroe, NY
1315
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.